Document is current
Any future updates will be listed below
-
Authors
Hind, Daniel http://orcid.org/0000-0002-6409-4793
Drabble, Sarah J.
Arden, Madelynne A.
Mandefield, Laura
Waterhouse, Simon
Maguire, Chin
Cantrill, Hannah
Robinson, Louisa
Beever, Daniel
Scott, Alexander J.
Keating, Sam
Hutchings, Marlene
Bradley, Judy
Nightingale, Julia
Allenby, Mark I.
Dewar, Jane
Whelan, Pauline
Ainsworth, John
Walters, Stephen J.
O’Cathain, Alicia
Wildman, Martin J.
-
Funding
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-1212-20015)
- License Information
-
More Information
Article History
Received: 6 July 2018
Accepted: 20 March 2019
First Online: 11 April 2019
Ethics approval and consent to participate
: Written informed consent was obtained prior to participation. The study received ethical approval from the London Brent Research Ethics Committee (16/LO/0356).
: Not applicable.
: Martin Wildman received funding from Zambon and support from Philips Respironics for the early intervention development work. This has not had any direct influence on the feasibility study reported here. In addition, Martin Wildman has worked with Pari to carry out studies using the e-track. This has not had any direct influence on the feasibility study reported here. The University of Manchester software team received funding from Pari to create a medication reporting component within the CFHealthHub software. This has not had any direct influence on the feasibility study reported here.The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
